[1]JournalofMedicinalChemistry,2016,vol.59,p.4948-4964
[1]Huang,Wei-Sheng;Liu,Shuangying;Zou,Dong;Thomas,Mathew;Wang,Yihan;Zhou,Tianjun;Romero,Jan;Kohlmann,Anna;Li,Feng;Qi,Jiwei;Cai,Lisi;Dwight,TimothyA.;Xu,Yongjin;Xu,Rongsong;Dodd,Rory;Toms,Angela;Parillon,Lois;Lu,Xiaohui;Anjum,Rana;Zhang,Sen;Wang,Frank;Keats,Jeffrey;Wardwell,ScottD.;Ning,Yaoyu;Xu,Qihong;Moran,LaurenE.;Mohemmad,QurishK.;Jang,HyunGyung;Clackson,Tim;Narasimhan,NarayanaI.;Rivera,VictorM.;Zhu,Xiaotian;Dalgarno,David;Shakespeare,WilliamC.[JournalofMedicinalChemistry,2016,vol.59,#10,p.4948-4964]
[1]Huang,Wei-Sheng;Liu,Shuangying;Zou,Dong;Thomas,Mathew;Wang,Yihan;Zhou,Tianjun;Romero,Jan;Kohlmann,Anna;Li,Feng;Qi,Jiwei;Cai,Lisi;Dwight,TimothyA.;Xu,Yongjin;Xu,Rongsong;Dodd,Rory;Toms,Angela;Parillon,Lois;Lu,Xiaohui;Anjum,Rana;Zhang,Sen;Wang,Frank;Keats,Jeffrey;Wardwell,ScottD.;Ning,Yaoyu;Xu,Qihong;Moran,LaurenE.;Mohemmad,QurishK.;Jang,HyunGyung;Clackson,Tim;Narasimhan,NarayanaI.;Rivera,VictorM.;Zhu,Xiaotian;Dalgarno,David;Shakespeare,WilliamC.[JournalofMedicinalChemistry,2016,vol.59,#10,p.4948-4964]
[1]Huang,Wei-Sheng;Liu,Shuangying;Zou,Dong;Thomas,Mathew;Wang,Yihan;Zhou,Tianjun;Romero,Jan;Kohlmann,Anna;Li,Feng;Qi,Jiwei;Cai,Lisi;Dwight,TimothyA.;Xu,Yongjin;Xu,Rongsong;Dodd,Rory;Toms,Angela;Parillon,Lois;Lu,Xiaohui;Anjum,Rana;Zhang,Sen;Wang,Frank;Keats,Jeffrey;Wardwell,ScottD.;Ning,Yaoyu;Xu,Qihong;Moran,LaurenE.;Mohemmad,QurishK.;Jang,HyunGyung;Clackson,Tim;Narasimhan,NarayanaI.;Rivera,VictorM.;Zhu,Xiaotian;Dalgarno,David;Shakespeare,WilliamC.[JournalofMedicinalChemistry,2016,vol.59,#10,p.4948-4964]
[1]JournalofMedicinalChemistry,2016,vol.59,p.4948-4964
Title: Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase.
Journal: Journal of medicinal chemistry 20160526
Title: Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20110503
Title: Sen Zhang, Frank Wang, Jeffrey Keats, Abstract LB-298: AP26113, a potent ALK inhibitor, overcomes mutations in EML4-ALK that confer resistance to PF-02341066 (PF1066). Cancer Research: April 15, 2010; Volume 70, Issue 8, Supplement 1
Title: Victor M. Rivera, Frank Wang, Rana Anjum, Abstract 1794: AP26113 is a dual ALK/EGFR inhibitor: Characterization against EGFR T790M in cell and mouse models of NSCLC. Cancer Research: April 15, 2012; Volume 72, Issue 8, Supplement 1